{"name":"Quotient Limited","slug":"quotient","ticker":"QTNT","exchange":"NASDAQ","domain":"quotientbd.com","description":"Quotient Limited (QTNT) is a diagnostics and transfusion medicine company focused on developing and commercializing innovative diagnostic solutions. The company's top drugs include Magellan and MosaiQ, which are used for blood grouping and transfusion medicine. Quotient Limited is a leading player in the diagnostics and transfusion medicine market, with a strong presence in the US and Europe.","hq":"Eysins, Switzerland","founded":0,"employees":"","ceo":"Manuel Rial Costas","sector":"Diagnostics / Transfusion Medicine","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$55M","metrics":{"revenue":30000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Magellan patent cliff ($10.0M at risk)","drug":"Magellan","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Quotient Limited Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Quotient Limited reported its fourth quarter and full year 2023 financial results, with revenue of $43.4 million and a net loss of $12.3 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Quotient Limited Announces Collaboration with a Leading Pharmaceutical Company","summary":"Quotient Limited announced a collaboration with a leading pharmaceutical company to develop and commercialize a new diagnostic test.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5oZjhkd0phM0pRNUlhcmtuMERoYWxPNnpLN0NvMnQxUTdVSUdUTDkwNTlZYWNtMktqYzZaTi1Eb0kyODNGcnJHTWpBbnBSTUYxRDJvOTZEc01Db01Ebkg4?oc=5","date":"2019-11-18","type":"pipeline","source":"ChartMill","summary":"QTNT Stock Price, Quote & Chart | QUOTIENT LTD (NASDAQ:QTNT) - ChartMill","headline":"QTNT Stock Price, Quote & Chart | QUOTIENT LTD (NASDAQ:QTNT)","sentiment":"neutral"}],"patents":[{"drugName":"Magellan","drugSlug":"blood-grouping","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":10000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Grifols","Bio-Rad Laboratories","Ortho Clinical Diagnostics"],"therapeuticFocus":["Blood Grouping and Transfusion Medicine"],"financials":null,"yahoo":null}